1. Home
  2. MDBH vs IVVD Comparison

MDBH vs IVVD Comparison

Compare MDBH & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDBH
  • IVVD
  • Stock Information
  • Founded
  • MDBH 1997
  • IVVD 2020
  • Country
  • MDBH United States
  • IVVD United States
  • Employees
  • MDBH N/A
  • IVVD N/A
  • Industry
  • MDBH
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDBH
  • IVVD Health Care
  • Exchange
  • MDBH Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • MDBH 66.8M
  • IVVD 66.6M
  • IPO Year
  • MDBH 2023
  • IVVD 2021
  • Fundamental
  • Price
  • MDBH $7.01
  • IVVD $1.38
  • Analyst Decision
  • MDBH
  • IVVD Strong Buy
  • Analyst Count
  • MDBH 0
  • IVVD 4
  • Target Price
  • MDBH N/A
  • IVVD $7.89
  • AVG Volume (30 Days)
  • MDBH 6.0K
  • IVVD 41.3M
  • Earning Date
  • MDBH 03-28-2025
  • IVVD 03-27-2025
  • Dividend Yield
  • MDBH N/A
  • IVVD N/A
  • EPS Growth
  • MDBH N/A
  • IVVD N/A
  • EPS
  • MDBH N/A
  • IVVD N/A
  • Revenue
  • MDBH $1,937,885.00
  • IVVD $11,564,000.00
  • Revenue This Year
  • MDBH N/A
  • IVVD N/A
  • Revenue Next Year
  • MDBH N/A
  • IVVD $599.08
  • P/E Ratio
  • MDBH N/A
  • IVVD N/A
  • Revenue Growth
  • MDBH N/A
  • IVVD N/A
  • 52 Week Low
  • MDBH $5.78
  • IVVD $0.36
  • 52 Week High
  • MDBH $12.70
  • IVVD $4.74
  • Technical
  • Relative Strength Index (RSI)
  • MDBH 61.96
  • IVVD 53.62
  • Support Level
  • MDBH $6.57
  • IVVD $1.15
  • Resistance Level
  • MDBH $7.98
  • IVVD $2.10
  • Average True Range (ATR)
  • MDBH 0.33
  • IVVD 0.47
  • MACD
  • MDBH 0.09
  • IVVD -0.04
  • Stochastic Oscillator
  • MDBH 49.08
  • IVVD 22.73

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: